Complications | 1-6 mn=45 patients | 7-12 mn= 20 patients | >12 mn= 46 patients | ||||||
---|---|---|---|---|---|---|---|---|---|
 | OR | LCI 95% | UCI 95% | OR | LCI 95% | UCI 95% | OR | LCI 95% | UCI 95% |
LTx | 2.5 | 0.2 | 25.8 | 4 | 0.3 | 47.1 | 12.7 | 1.5 | 103 |
acute liver failure | 2.5 | 0.1 | 63.9 | 15 | 0.7 | 306.4 | 2.4 | 0.09 | 62.4 |
Carcinoma | 2.5 | 0.2 | 25.8 | 6.3 | 0.6 | 65.6 | 12.7 | 1.5 | 103 |
Cirrhosis | 8.1 | 0.4 | 156.1 | 41.6 | 2.2 | 779.9 | 40.5 | 2.3 | 704.1 |
hepatomegaly | 3.3 | 0.9 | 11.3 | 4.4 | 1.1 | 17.7 | 3.9 | 1.1 | 13.3 |
Rickets | 4.3 | 0.2 | 92.6 | 10.1 | 0.5 | 222.1 | 19 | 1.1 | 338.3 |
renal dysfunction | 1.7 | 0.2 | 9.8 | 5.8 | 1.0 | 33.4 | 5.5 | 1.1 | 26.6 |
renal tubular dysfunction | 1.2 | 0.1 | 7.9 | 1.9 | 0.2 | 14.9 | 4.3 | 0.8 | 21.6 |
nephromegaly | 0.8 | 0.1 | 6 | 3.0 | 0.4 | 20.2 | 2.6 | 0.4 | 13.8 |
nephrocalcinosis | 4.3 | 0.2 | 92.6 | 5.7 | 0.2 | 148.3 | 2.5 | 0.09 | 62.5 |
impaired growth | 2,5 | 0.1 | 63.9 | 1.8 | 0.03 | 95.6 | 2.5 | 0.09 | 62.5 |
Adipositas | 2.5 | 0.1 | 63.9 | 1.8 | 0.03 | 95.6 | 2.5 | 0.09 | 62.5 |
neurological concomitant disease | 1.4 | 0.3 | 6.3 | 0.5 | 0.05 | 6.1 | 0.2 | 0.02 | 2.5 |
neurological crises | 0.2 | 0.02 | 2.5 | 0.5 | 0.05 | 6.1 | 0.2 | 0.02 | 2.5 |
Epilepsy/convulsion | 0.8 | 0.1 | 3.4 | 0.9 | 0.1 | 5.5 | 0.1 | 0.02 | 1.7 |
ADS, behavioural disorders | 1.4 | 0.3 | 6.3 | 1.2 | 0.1 | 8.2 | 0.5 | 0.08 | 3.2 |
learning/language difficulties | 0.8 | 0.05 | 13.5 | 0.5 | 0.02 | 15.2 | 0.2 | 0.01 | 6.6 |
Impaired psychomotor development | 0.7 | 0.2 | 2.3 | 1.5 | 0.4 | 5.34 | 0.7 | 0.2 | 2.27 |
Death | 0.8 | 0.01 | 42.5 | 15 | 0.7 | 306.4 | 2.5 | 0.09 | 62.5 |